nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—liver cancer—sclerosing cholangitis	0.916	1	CtDrD
Sorafenib—ABCC2—bile canaliculus—sclerosing cholangitis	0.0164	0.279	CbGeAlD
Sorafenib—ABCC2—bile duct—sclerosing cholangitis	0.00511	0.087	CbGeAlD
Sorafenib—ABCC2—bile—sclerosing cholangitis	0.00393	0.0669	CbGeAlD
Sorafenib—PDGFRA—gall bladder—sclerosing cholangitis	0.00181	0.0308	CbGeAlD
Sorafenib—HIPK3—pancreas—sclerosing cholangitis	0.00148	0.0253	CbGeAlD
Sorafenib—KIT—gall bladder—sclerosing cholangitis	0.00145	0.0247	CbGeAlD
Sorafenib—PDGFRB—gall bladder—sclerosing cholangitis	0.00141	0.0241	CbGeAlD
Sorafenib—CDK7—liver—sclerosing cholangitis	0.00112	0.019	CbGeAlD
Sorafenib—TAOK2—liver—sclerosing cholangitis	0.00111	0.0189	CbGeAlD
Sorafenib—ABCC4—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00107	0.0419	CbGpPWpGaD
Sorafenib—MKNK2—pancreas—sclerosing cholangitis	0.00104	0.0177	CbGeAlD
Sorafenib—ZAK—liver—sclerosing cholangitis	0.000964	0.0164	CbGeAlD
Sorafenib—HIPK3—liver—sclerosing cholangitis	0.000944	0.0161	CbGeAlD
Sorafenib—RALBP1—pancreas—sclerosing cholangitis	0.000936	0.0159	CbGeAlD
Sorafenib—TIE1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000908	0.0355	CbGpPWpGaD
Sorafenib—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.000904	0.0353	CbGpPWpGaD
Sorafenib—FLT1—pancreas—sclerosing cholangitis	0.000891	0.0152	CbGeAlD
Sorafenib—RAF1—pancreas—sclerosing cholangitis	0.000886	0.0151	CbGeAlD
Sorafenib—TIE1—liver—sclerosing cholangitis	0.000882	0.015	CbGeAlD
Sorafenib—BRAF—liver—sclerosing cholangitis	0.000846	0.0144	CbGeAlD
Sorafenib—EPHX2—liver—sclerosing cholangitis	0.000808	0.0138	CbGeAlD
Sorafenib—MAPK11—CDO in myogenesis—TCF4—sclerosing cholangitis	0.000805	0.0315	CbGpPWpGaD
Sorafenib—FLT3—liver—sclerosing cholangitis	0.000802	0.0137	CbGeAlD
Sorafenib—EPHX2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000789	0.0308	CbGpPWpGaD
Sorafenib—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000756	0.0296	CbGpPWpGaD
Sorafenib—UGT1A9—liver—sclerosing cholangitis	0.000739	0.0126	CbGeAlD
Sorafenib—FLT4—liver—sclerosing cholangitis	0.000729	0.0124	CbGeAlD
Sorafenib—FLT1—Angiogenesis—HIF1A—sclerosing cholangitis	0.000725	0.0283	CbGpPWpGaD
Sorafenib—FGFR1—liver—sclerosing cholangitis	0.000719	0.0122	CbGeAlD
Sorafenib—MAP3K7—liver—sclerosing cholangitis	0.000681	0.0116	CbGeAlD
Sorafenib—KIT—pancreas—sclerosing cholangitis	0.000667	0.0114	CbGeAlD
Sorafenib—MKNK2—liver—sclerosing cholangitis	0.00066	0.0112	CbGeAlD
Sorafenib—PDGFRB—pancreas—sclerosing cholangitis	0.000652	0.0111	CbGeAlD
Sorafenib—MKNK1—liver—sclerosing cholangitis	0.000651	0.0111	CbGeAlD
Sorafenib—FLT1—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.000623	0.0244	CbGpPWpGaD
Sorafenib—CYP3A7—liver—sclerosing cholangitis	0.000615	0.0105	CbGeAlD
Sorafenib—RALBP1—liver—sclerosing cholangitis	0.000596	0.0101	CbGeAlD
Sorafenib—FLT1—liver—sclerosing cholangitis	0.000567	0.00965	CbGeAlD
Sorafenib—RAF1—liver—sclerosing cholangitis	0.000563	0.0096	CbGeAlD
Sorafenib—MKNK1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.000542	0.0212	CbGpPWpGaD
Sorafenib—STK10—liver—sclerosing cholangitis	0.000536	0.00914	CbGeAlD
Sorafenib—PDGFRA—liver—sclerosing cholangitis	0.000531	0.00904	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—liver—sclerosing cholangitis	0.000523	0.0089	CbGeAlD
Sorafenib—ABCC4—pancreas—sclerosing cholangitis	0.000519	0.00884	CbGeAlD
Sorafenib—UGT1A1—liver—sclerosing cholangitis	0.000507	0.00863	CbGeAlD
Sorafenib—KDR—Angiogenesis—HIF1A—sclerosing cholangitis	0.000482	0.0189	CbGpPWpGaD
Sorafenib—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000482	0.0188	CbGpPWpGaD
Sorafenib—MAP2K5—liver—sclerosing cholangitis	0.000479	0.00816	CbGeAlD
Sorafenib—KDR—liver—sclerosing cholangitis	0.000479	0.00816	CbGeAlD
Sorafenib—CSF1R—liver—sclerosing cholangitis	0.000468	0.00796	CbGeAlD
Sorafenib—MAP3K7—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.000455	0.0178	CbGpPWpGaD
Sorafenib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.000425	0.0166	CbGpPWpGaD
Sorafenib—KIT—liver—sclerosing cholangitis	0.000425	0.00723	CbGeAlD
Sorafenib—PDGFRB—liver—sclerosing cholangitis	0.000415	0.00706	CbGeAlD
Sorafenib—MAPK11—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.000376	0.0147	CbGpPWpGaD
Sorafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000356	0.0139	CbGpPWpGaD
Sorafenib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.000354	0.0138	CbGpPWpGaD
Sorafenib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.000349	0.0136	CbGpPWpGaD
Sorafenib—HTR2B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.000347	0.0136	CbGpPWpGaD
Sorafenib—CYP3A5—pancreas—sclerosing cholangitis	0.00034	0.00579	CbGeAlD
Sorafenib—FGFR1—Endochondral Ossification—ALPL—sclerosing cholangitis	0.000336	0.0131	CbGpPWpGaD
Sorafenib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000332	0.013	CbGpPWpGaD
Sorafenib—ABCC4—liver—sclerosing cholangitis	0.00033	0.00562	CbGeAlD
Sorafenib—ABCC2—liver—sclerosing cholangitis	0.00032	0.00544	CbGeAlD
Sorafenib—BRAF—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.000317	0.0124	CbGpPWpGaD
Sorafenib—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.000308	0.012	CbGpPWpGaD
Sorafenib—UGT1A9—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.000303	0.0118	CbGpPWpGaD
Sorafenib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.000297	0.0116	CbGpPWpGaD
Sorafenib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000284	0.0111	CbGpPWpGaD
Sorafenib—KDR—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.000282	0.011	CbGpPWpGaD
Sorafenib—HTR2C—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00028	0.011	CbGpPWpGaD
Sorafenib—MAPK11—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.000279	0.0109	CbGpPWpGaD
Sorafenib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.000278	0.0108	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000275	0.0107	CbGpPWpGaD
Sorafenib—CYP2C19—liver—sclerosing cholangitis	0.000275	0.00468	CbGeAlD
Sorafenib—RAF1—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.000262	0.0103	CbGpPWpGaD
Sorafenib—MAP3K7—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.000262	0.0102	CbGpPWpGaD
Sorafenib—FGFR1—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.000254	0.00992	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000252	0.00984	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000251	0.00981	CbGpPWpGaD
Sorafenib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.000245	0.00957	CbGpPWpGaD
Sorafenib—CYP2C8—liver—sclerosing cholangitis	0.00024	0.00408	CbGeAlD
Sorafenib—ABCG2—liver—sclerosing cholangitis	0.000233	0.00397	CbGeAlD
Sorafenib—CYP1A2—liver—sclerosing cholangitis	0.000224	0.00382	CbGeAlD
Sorafenib—RAF1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.000219	0.00857	CbGpPWpGaD
Sorafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000219	0.00856	CbGpPWpGaD
Sorafenib—CYP3A5—liver—sclerosing cholangitis	0.000216	0.00368	CbGeAlD
Sorafenib—CYP2B6—liver—sclerosing cholangitis	0.000215	0.00366	CbGeAlD
Sorafenib—CYP2C9—liver—sclerosing cholangitis	0.000213	0.00363	CbGeAlD
Sorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.000204	0.00799	CbGpPWpGaD
Sorafenib—RET—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.000202	0.0079	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000202	0.00788	CbGpPWpGaD
Sorafenib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.000185	0.00725	CbGpPWpGaD
Sorafenib—MAPK11—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.000184	0.00718	CbGpPWpGaD
Sorafenib—ABCB1—pancreas—sclerosing cholangitis	0.000181	0.00308	CbGeAlD
Sorafenib—MAPK11—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000166	0.00649	CbGpPWpGaD
Sorafenib—CYP3A4—liver—sclerosing cholangitis	0.000162	0.00276	CbGeAlD
Sorafenib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00016	0.00626	CbGpPWpGaD
Sorafenib—CYP2D6—liver—sclerosing cholangitis	0.00016	0.00272	CbGeAlD
Sorafenib—RAF1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.000159	0.00623	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.000159	0.0062	CbGpPWpGaD
Sorafenib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.000157	0.00613	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TCF4—sclerosing cholangitis	0.000149	0.00583	CbGpPWpGaD
Sorafenib—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.000149	0.00581	CbGpPWpGaD
Sorafenib—UGT1A9—Phase II conjugation—GGT1—sclerosing cholangitis	0.000149	0.00581	CbGpPWpGaD
Sorafenib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.000143	0.00559	CbGpPWpGaD
Sorafenib—RAF1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.000141	0.00549	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000134	0.00525	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000133	0.0052	CbGpPWpGaD
Sorafenib—RAF1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.000128	0.00501	CbGpPWpGaD
Sorafenib—RAF1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.000127	0.00495	CbGpPWpGaD
Sorafenib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000123	0.00481	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—ABCB4—sclerosing cholangitis	0.000122	0.00479	CbGpPWpGaD
Sorafenib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000121	0.00473	CbGpPWpGaD
Sorafenib—RAF1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.000115	0.0045	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000115	0.00449	CbGpPWpGaD
Sorafenib—ABCB1—liver—sclerosing cholangitis	0.000115	0.00196	CbGeAlD
Sorafenib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000115	0.00448	CbGpPWpGaD
Sorafenib—ABCC4—NRF2 pathway—GGT1—sclerosing cholangitis	0.000115	0.00448	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000113	0.00441	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000112	0.00438	CbGpPWpGaD
Sorafenib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00011	0.00431	CbGpPWpGaD
Sorafenib—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00011	0.00429	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000103	0.00404	CbGpPWpGaD
Sorafenib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0001	0.00392	CbGpPWpGaD
Sorafenib—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0001	0.00391	CbGpPWpGaD
Sorafenib—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	9.91e-05	0.00387	CbGpPWpGaD
Sorafenib—UGT1A9—NRF2 pathway—GGT1—sclerosing cholangitis	9.91e-05	0.00387	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TCF4—sclerosing cholangitis	9.69e-05	0.00379	CbGpPWpGaD
Sorafenib—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	9.67e-05	0.00378	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	9.51e-05	0.00372	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	9.44e-05	0.00369	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	9.42e-05	0.00368	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—BCL2L11—sclerosing cholangitis	9.21e-05	0.0036	CbGpPWpGaD
Sorafenib—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	8.69e-05	0.0034	CbGpPWpGaD
Sorafenib—UGT1A9—Biological oxidations—GGT1—sclerosing cholangitis	8.69e-05	0.0034	CbGpPWpGaD
Sorafenib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	8.55e-05	0.00334	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TCF4—sclerosing cholangitis	8.33e-05	0.00326	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	8.21e-05	0.00321	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	8.14e-05	0.00318	CbGpPWpGaD
Sorafenib—CYP3A7—Biological oxidations—GGT1—sclerosing cholangitis	7.31e-05	0.00286	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TCF4—sclerosing cholangitis	7.13e-05	0.00279	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—BCL2L11—sclerosing cholangitis	6.87e-05	0.00268	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—BCL2L11—sclerosing cholangitis	6.76e-05	0.00264	CbGpPWpGaD
Sorafenib—MAPK11—Cellular responses to stress—HIF1A—sclerosing cholangitis	6.09e-05	0.00238	CbGpPWpGaD
Sorafenib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	5.97e-05	0.00233	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—GOT2—sclerosing cholangitis	5.82e-05	0.00227	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TCF4—sclerosing cholangitis	5.71e-05	0.00223	CbGpPWpGaD
Sorafenib—MKNK1—Disease—GOT2—sclerosing cholangitis	5.66e-05	0.00221	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	5.6e-05	0.00219	CbGpPWpGaD
Sorafenib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	5.44e-05	0.00213	CbGpPWpGaD
Sorafenib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	5.43e-05	0.00212	CbGpPWpGaD
Sorafenib—CYP2B6—Biological oxidations—GGT1—sclerosing cholangitis	5.41e-05	0.00211	CbGpPWpGaD
Sorafenib—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	5.28e-05	0.00206	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—BCL2L11—sclerosing cholangitis	5.04e-05	0.00197	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—GOT1—sclerosing cholangitis	5.02e-05	0.00196	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—GGT1—sclerosing cholangitis	5.02e-05	0.00196	CbGpPWpGaD
Sorafenib—MKNK1—Disease—GOT1—sclerosing cholangitis	4.89e-05	0.00191	CbGpPWpGaD
Sorafenib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	4.58e-05	0.00179	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	4.44e-05	0.00174	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	4.29e-05	0.00167	CbGpPWpGaD
Sorafenib—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	4.08e-05	0.0016	CbGpPWpGaD
Sorafenib—CDK7—Disease—GOT2—sclerosing cholangitis	3.99e-05	0.00156	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	3.82e-05	0.00149	CbGpPWpGaD
Sorafenib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	3.76e-05	0.00147	CbGpPWpGaD
Sorafenib—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	3.72e-05	0.00146	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ABCB4—sclerosing cholangitis	3.62e-05	0.00142	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	3.62e-05	0.00142	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	3.49e-05	0.00136	CbGpPWpGaD
Sorafenib—CDK7—Disease—GOT1—sclerosing cholangitis	3.45e-05	0.00135	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	3.44e-05	0.00135	CbGpPWpGaD
Sorafenib—MKNK1—Disease—HIF1A—sclerosing cholangitis	3.4e-05	0.00133	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—BCL2L11—sclerosing cholangitis	3.35e-05	0.00131	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	3.34e-05	0.0013	CbGpPWpGaD
Sorafenib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	3.18e-05	0.00124	CbGpPWpGaD
Sorafenib—MKNK1—Disease—NOS2—sclerosing cholangitis	3.09e-05	0.00121	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	3.08e-05	0.0012	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ABCB4—sclerosing cholangitis	3.05e-05	0.00119	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	2.98e-05	0.00116	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—HIF1A—sclerosing cholangitis	2.92e-05	0.00114	CbGpPWpGaD
Sorafenib—BRAF—Disease—GOT2—sclerosing cholangitis	2.89e-05	0.00113	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.89e-05	0.00113	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—HIF1A—sclerosing cholangitis	2.87e-05	0.00112	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.86e-05	0.00112	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—NOS2—sclerosing cholangitis	2.68e-05	0.00105	CbGpPWpGaD
Sorafenib—KIT—Disease—GOT2—sclerosing cholangitis	2.63e-05	0.00103	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.6e-05	0.00102	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.6e-05	0.00102	CbGpPWpGaD
Sorafenib—FGFR1—Disease—GOT2—sclerosing cholangitis	2.5e-05	0.000976	CbGpPWpGaD
Sorafenib—BRAF—Disease—GOT1—sclerosing cholangitis	2.5e-05	0.000975	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—GOT2—sclerosing cholangitis	2.49e-05	0.000973	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.47e-05	0.000965	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.46e-05	0.000962	CbGpPWpGaD
Sorafenib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	2.46e-05	0.00096	CbGpPWpGaD
Sorafenib—CDK7—Disease—HIF1A—sclerosing cholangitis	2.4e-05	0.000937	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—HIF1A—sclerosing cholangitis	2.38e-05	0.000931	CbGpPWpGaD
Sorafenib—KIT—Disease—GOT1—sclerosing cholangitis	2.27e-05	0.000888	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—NOS2—sclerosing cholangitis	2.26e-05	0.000882	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ABCB4—sclerosing cholangitis	2.25e-05	0.000881	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—GOT2—sclerosing cholangitis	2.24e-05	0.000877	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.22e-05	0.000867	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	2.2e-05	0.000861	CbGpPWpGaD
Sorafenib—CDK7—Disease—NOS2—sclerosing cholangitis	2.18e-05	0.000852	CbGpPWpGaD
Sorafenib—FGFR1—Disease—GOT1—sclerosing cholangitis	2.16e-05	0.000842	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—GOT1—sclerosing cholangitis	2.15e-05	0.00084	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—HIF1A—sclerosing cholangitis	2.14e-05	0.000838	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	2.12e-05	0.000827	CbGpPWpGaD
Sorafenib—RAF1—Disease—GOT2—sclerosing cholangitis	2e-05	0.000782	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—BCL2L11—sclerosing cholangitis	1.98e-05	0.000773	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—GOT1—sclerosing cholangitis	1.94e-05	0.000757	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	1.91e-05	0.000746	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	1.76e-05	0.000687	CbGpPWpGaD
Sorafenib—BRAF—Disease—HIF1A—sclerosing cholangitis	1.74e-05	0.000678	CbGpPWpGaD
Sorafenib—RAF1—Disease—GOT1—sclerosing cholangitis	1.73e-05	0.000675	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	1.72e-05	0.000673	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GOT2—sclerosing cholangitis	1.72e-05	0.000673	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—BCL2L11—sclerosing cholangitis	1.71e-05	0.000667	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	1.7e-05	0.000666	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	1.66e-05	0.00065	CbGpPWpGaD
Sorafenib—KIT—Disease—HIF1A—sclerosing cholangitis	1.58e-05	0.000618	CbGpPWpGaD
Sorafenib—BRAF—Disease—NOS2—sclerosing cholangitis	1.58e-05	0.000617	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	1.57e-05	0.000613	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	1.57e-05	0.000612	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	1.55e-05	0.000607	CbGpPWpGaD
Sorafenib—FGFR1—Disease—HIF1A—sclerosing cholangitis	1.5e-05	0.000586	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	1.5e-05	0.000585	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	1.49e-05	0.000581	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	1.49e-05	0.000581	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GGT1—sclerosing cholangitis	1.49e-05	0.000581	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GOT1—sclerosing cholangitis	1.49e-05	0.000581	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	1.46e-05	0.000572	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	1.46e-05	0.000571	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GOT2—sclerosing cholangitis	1.45e-05	0.000566	CbGpPWpGaD
Sorafenib—KIT—Disease—NOS2—sclerosing cholangitis	1.44e-05	0.000562	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	1.43e-05	0.000559	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HIF1A—sclerosing cholangitis	1.43e-05	0.000558	CbGpPWpGaD
Sorafenib—FGFR1—Disease—NOS2—sclerosing cholangitis	1.36e-05	0.000533	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—NOS2—sclerosing cholangitis	1.36e-05	0.000532	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	1.35e-05	0.000527	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	1.33e-05	0.000519	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	1.26e-05	0.000493	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	1.26e-05	0.000493	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GGT1—sclerosing cholangitis	1.25e-05	0.000489	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GOT1—sclerosing cholangitis	1.25e-05	0.000489	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HIF1A—sclerosing cholangitis	1.23e-05	0.00048	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—NOS2—sclerosing cholangitis	1.23e-05	0.000479	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	1.22e-05	0.000478	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HIF1A—sclerosing cholangitis	1.22e-05	0.000475	CbGpPWpGaD
Sorafenib—RAF1—Disease—HIF1A—sclerosing cholangitis	1.2e-05	0.000469	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HIF1A—sclerosing cholangitis	1.11e-05	0.000432	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	1.11e-05	0.000432	CbGpPWpGaD
Sorafenib—RAF1—Disease—NOS2—sclerosing cholangitis	1.09e-05	0.000427	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GOT2—sclerosing cholangitis	1.07e-05	0.000419	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HIF1A—sclerosing cholangitis	1.05e-05	0.00041	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	1.05e-05	0.000409	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	1.05e-05	0.000409	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	1.02e-05	0.0004	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	9.44e-06	0.000369	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GGT1—sclerosing cholangitis	9.24e-06	0.000361	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GOT1—sclerosing cholangitis	9.24e-06	0.000361	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	9.07e-06	0.000354	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	9.04e-06	0.000353	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	9.04e-06	0.000353	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HIF1A—sclerosing cholangitis	9e-06	0.000352	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HIF1A—sclerosing cholangitis	8.41e-06	0.000329	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	8.09e-06	0.000316	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	7.9e-06	0.000309	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	7.83e-06	0.000306	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	7.83e-06	0.000306	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	7.44e-06	0.000291	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	7.38e-06	0.000288	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HIF1A—sclerosing cholangitis	7.26e-06	0.000284	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	6.99e-06	0.000273	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	6.99e-06	0.000273	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	6.82e-06	0.000266	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	6.82e-06	0.000266	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	6.43e-06	0.000251	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	6.43e-06	0.000251	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	6.37e-06	0.000249	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	6.37e-06	0.000249	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	6.31e-06	0.000246	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	5.44e-06	0.000213	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	5.44e-06	0.000213	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	4.87e-06	0.00019	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.2e-06	0.000164	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.2e-06	0.000164	CbGpPWpGaD
